5-Chloro-3-(2-methylimidazol-1-ylmethyl)-pyridazine → 5-(3-tert-Butyl-phenyl)-3-(2-methyl-imidazol-1-yl-methyl)-pyridazine Hydrochloride
Reaktionsgleichung
[C:1]([C:5]1[CH:6]=[C:7](B2OC(C)(C)C(C)(C)O2)[CH:8]=[CH:9][CH:10]=1)([CH3:4])([CH3:3])[CH3:2].[Cl:20][C:21]1[CH:22]=[C:23]([CH2:27][N:28]2[CH:32]=[CH:31][N:30]=[C:29]2[CH3:33])[N:24]=[N:25][CH:26]=1>>[ClH:20].[C:1]([C:5]1[CH:6]=[C:7]([C:21]2[CH:22]=[C:23]([CH2:27][N:28]3[CH:32]=[CH:31][N:30]=[C:29]3[CH3:33])[N:24]=[N:25][CH:26]=2)[CH:8]=[CH:9][CH:10]=1)([CH3:2])([CH3:3])[CH3:4]Komponenten
3
Versuchsvorschrift
The title compound, MS: m/e=307.3 (M+H+), was prepared from 2-(3-tert-butylphenyl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane and 5-chloro-3-(2-methyl-imidazol-1-yl-methyl)-pyridazine.
Quellen und Nachweise
- ORD-Eintrag
- ord-4c8969f08a5247a29078330c343286ba
- Quelldatensatz
- uspto-grants-2006_02